Similarly, Cheng utilized KAAD-cyclopamine to inhibit the SHH signaling pathway, resulting in the inhibition of DNA synthesis, cell growth, invasiveness, and cell motility in HCC cells [36]. This evidence concerns the gene SHH and hepatocellular carcinoma.